Aside from the primary CMI assays, additional T cell based assays such as dual ELISpot (IFN-γ and granzyme B) will be performed as an exploratory endpoint since ELISpot has shown to be a sensitive assay to measure influenza-specific CMI [21, 22]. This evidence concerns the gene IFNG and influenza.